Frequencies of activated (HLA-DR+CD38+ or Ki67+) CD8+ and CD4+ T cells (Fig S8A-B) and activated CX3CR1+ CD8+ T cells (Fig S8D) remained elevated in MIS-C even when compared to the severe subgroup of pediatric COVID-19. This evidence concerns the gene CD8A and COVID-19.